Loading…

Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations

A simple and rapid reversed phase liquid chromatographic method for separation and determination of the related substances of telmisartan (TLM) was developed and validated. The chromatographic separation was achieved on Lichrospher RP-18 column (250×4.6mm, 5μm), using 20mM ammonium acetate containin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 2011-11, Vol.56 (3), p.471-478
Main Authors: Nageswara Rao, R., Guru Prasad, K., Gangu Naidu, Ch, Maurya, Pawan K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c409t-e48e7aa669255776d9d62a082556276bd98f09738ab97063d07220ce6ca869143
cites cdi_FETCH-LOGICAL-c409t-e48e7aa669255776d9d62a082556276bd98f09738ab97063d07220ce6ca869143
container_end_page 478
container_issue 3
container_start_page 471
container_title Journal of pharmaceutical and biomedical analysis
container_volume 56
creator Nageswara Rao, R.
Guru Prasad, K.
Gangu Naidu, Ch
Maurya, Pawan K.
description A simple and rapid reversed phase liquid chromatographic method for separation and determination of the related substances of telmisartan (TLM) was developed and validated. The chromatographic separation was achieved on Lichrospher RP-18 column (250×4.6mm, 5μm), using 20mM ammonium acetate containing 0.1% (v/v) triethylamine (pH adjusted to 3.0 with trifluoroacetic acid) and acetonitrile as mobile phase at 25°C. The detection was performed at 254nm. The method was validated and found to be robust, precise, specific and linear between 0.37 and 500μg/mL. The limits of detection and quantification of telmisartan were 0.11 and 0.37μg/mL, respectively. The method was successfully applied to quantify related substances and assay of TLM in bulk drugs and commercial tablets. The related substances relate to a novel synthetic route and different from those A-H impurities reported by European Pharmacopeia.
doi_str_mv 10.1016/j.jpba.2011.05.043
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_882127626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708511003207</els_id><sourcerecordid>882127626</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-e48e7aa669255776d9d62a082556276bd98f09738ab97063d07220ce6ca869143</originalsourceid><addsrcrecordid>eNp9kc2O1DAQhCMEYmcXXoAD-II4zdB2EjuWuKwWFpBW4gArcbMcuzPjwYlnbWckXoJnxvMD3DhZ3fqq3KqqqhcUVhQof7tdbXe9XjGgdAXtCpr6UbWgnaiXjDffH1cLEDVdCujai-oypS0AtFQ2T6sLRgWVjIlF9es97tGH3YhTJmEgmuy1d1ZntMS7h9lZYjYxjDqHddS7jTNkxLwJlgwhEosZ4-gmnV2YDvKI_ihNc5-yngymwzajH13SsWyIm0g_-x_ExnmdiJ6ORuPsjxbpWfVk0D7h8_N7Vd3ffvh282l59-Xj55vru6VpQOYlNh0KrTmXrG2F4FZazjR0ZeJM8N7KbgAp6k73UgCvLQjGwCA3uuOSNvVV9ebku4vhYcaUVTnQoPd6wjAn1XWMFiPGC8lOpIkhpYiD2kU36vhTUVCHGtRWHWpQhxoUtKrUUEQvz_ZzP6L9K_mTewFenwGdjPZDLFm59I9rGsEkl4V7deIGHZRex8Lcfy0_tQCUgaBQiHcnAktce4dRJeOwJG9dRJOVDe5_l_4GAC2xTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>882127626</pqid></control><display><type>article</type><title>Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations</title><source>ScienceDirect Journals</source><creator>Nageswara Rao, R. ; Guru Prasad, K. ; Gangu Naidu, Ch ; Maurya, Pawan K.</creator><creatorcontrib>Nageswara Rao, R. ; Guru Prasad, K. ; Gangu Naidu, Ch ; Maurya, Pawan K.</creatorcontrib><description>A simple and rapid reversed phase liquid chromatographic method for separation and determination of the related substances of telmisartan (TLM) was developed and validated. The chromatographic separation was achieved on Lichrospher RP-18 column (250×4.6mm, 5μm), using 20mM ammonium acetate containing 0.1% (v/v) triethylamine (pH adjusted to 3.0 with trifluoroacetic acid) and acetonitrile as mobile phase at 25°C. The detection was performed at 254nm. The method was validated and found to be robust, precise, specific and linear between 0.37 and 500μg/mL. The limits of detection and quantification of telmisartan were 0.11 and 0.37μg/mL, respectively. The method was successfully applied to quantify related substances and assay of TLM in bulk drugs and commercial tablets. The related substances relate to a novel synthetic route and different from those A-H impurities reported by European Pharmacopeia.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2011.05.043</identifier><identifier>PMID: 21719227</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>acetonitrile ; Acetonitriles - analysis ; Acetonitriles - chemistry ; ammonium acetate ; Analysis ; Analytical, structural and metabolic biochemistry ; Benzimidazoles - analysis ; Benzimidazoles - chemistry ; Benzoates - analysis ; Benzoates - chemistry ; Biological and medical sciences ; Bulk drugs ; Chemistry, Pharmaceutical - methods ; Chromatography, Liquid - methods ; detection limit ; Drug Contamination ; Ethylamines - analysis ; Ethylamines - chemistry ; Fundamental and applied biological sciences. Psychology ; General pharmacology ; Hypertension ; Medical sciences ; Pharmacology. Drug treatments ; Quality Control ; Related substances ; Reproducibility of Results ; reversed-phase liquid chromatography ; RP-HPLC ; Tablets - analysis ; Tablets - chemistry ; Telmisartan ; triethylamine</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2011-11, Vol.56 (3), p.471-478</ispartof><rights>2011 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-e48e7aa669255776d9d62a082556276bd98f09738ab97063d07220ce6ca869143</citedby><cites>FETCH-LOGICAL-c409t-e48e7aa669255776d9d62a082556276bd98f09738ab97063d07220ce6ca869143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24472969$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21719227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nageswara Rao, R.</creatorcontrib><creatorcontrib>Guru Prasad, K.</creatorcontrib><creatorcontrib>Gangu Naidu, Ch</creatorcontrib><creatorcontrib>Maurya, Pawan K.</creatorcontrib><title>Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>A simple and rapid reversed phase liquid chromatographic method for separation and determination of the related substances of telmisartan (TLM) was developed and validated. The chromatographic separation was achieved on Lichrospher RP-18 column (250×4.6mm, 5μm), using 20mM ammonium acetate containing 0.1% (v/v) triethylamine (pH adjusted to 3.0 with trifluoroacetic acid) and acetonitrile as mobile phase at 25°C. The detection was performed at 254nm. The method was validated and found to be robust, precise, specific and linear between 0.37 and 500μg/mL. The limits of detection and quantification of telmisartan were 0.11 and 0.37μg/mL, respectively. The method was successfully applied to quantify related substances and assay of TLM in bulk drugs and commercial tablets. The related substances relate to a novel synthetic route and different from those A-H impurities reported by European Pharmacopeia.</description><subject>acetonitrile</subject><subject>Acetonitriles - analysis</subject><subject>Acetonitriles - chemistry</subject><subject>ammonium acetate</subject><subject>Analysis</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Benzimidazoles - analysis</subject><subject>Benzimidazoles - chemistry</subject><subject>Benzoates - analysis</subject><subject>Benzoates - chemistry</subject><subject>Biological and medical sciences</subject><subject>Bulk drugs</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Chromatography, Liquid - methods</subject><subject>detection limit</subject><subject>Drug Contamination</subject><subject>Ethylamines - analysis</subject><subject>Ethylamines - chemistry</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General pharmacology</subject><subject>Hypertension</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Quality Control</subject><subject>Related substances</subject><subject>Reproducibility of Results</subject><subject>reversed-phase liquid chromatography</subject><subject>RP-HPLC</subject><subject>Tablets - analysis</subject><subject>Tablets - chemistry</subject><subject>Telmisartan</subject><subject>triethylamine</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kc2O1DAQhCMEYmcXXoAD-II4zdB2EjuWuKwWFpBW4gArcbMcuzPjwYlnbWckXoJnxvMD3DhZ3fqq3KqqqhcUVhQof7tdbXe9XjGgdAXtCpr6UbWgnaiXjDffH1cLEDVdCujai-oypS0AtFQ2T6sLRgWVjIlF9es97tGH3YhTJmEgmuy1d1ZntMS7h9lZYjYxjDqHddS7jTNkxLwJlgwhEosZ4-gmnV2YDvKI_ihNc5-yngymwzajH13SsWyIm0g_-x_ExnmdiJ6ORuPsjxbpWfVk0D7h8_N7Vd3ffvh282l59-Xj55vru6VpQOYlNh0KrTmXrG2F4FZazjR0ZeJM8N7KbgAp6k73UgCvLQjGwCA3uuOSNvVV9ebku4vhYcaUVTnQoPd6wjAn1XWMFiPGC8lOpIkhpYiD2kU36vhTUVCHGtRWHWpQhxoUtKrUUEQvz_ZzP6L9K_mTewFenwGdjPZDLFm59I9rGsEkl4V7deIGHZRex8Lcfy0_tQCUgaBQiHcnAktce4dRJeOwJG9dRJOVDe5_l_4GAC2xTQ</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Nageswara Rao, R.</creator><creator>Guru Prasad, K.</creator><creator>Gangu Naidu, Ch</creator><creator>Maurya, Pawan K.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20111101</creationdate><title>Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations</title><author>Nageswara Rao, R. ; Guru Prasad, K. ; Gangu Naidu, Ch ; Maurya, Pawan K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-e48e7aa669255776d9d62a082556276bd98f09738ab97063d07220ce6ca869143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>acetonitrile</topic><topic>Acetonitriles - analysis</topic><topic>Acetonitriles - chemistry</topic><topic>ammonium acetate</topic><topic>Analysis</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Benzimidazoles - analysis</topic><topic>Benzimidazoles - chemistry</topic><topic>Benzoates - analysis</topic><topic>Benzoates - chemistry</topic><topic>Biological and medical sciences</topic><topic>Bulk drugs</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Chromatography, Liquid - methods</topic><topic>detection limit</topic><topic>Drug Contamination</topic><topic>Ethylamines - analysis</topic><topic>Ethylamines - chemistry</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General pharmacology</topic><topic>Hypertension</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Quality Control</topic><topic>Related substances</topic><topic>Reproducibility of Results</topic><topic>reversed-phase liquid chromatography</topic><topic>RP-HPLC</topic><topic>Tablets - analysis</topic><topic>Tablets - chemistry</topic><topic>Telmisartan</topic><topic>triethylamine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nageswara Rao, R.</creatorcontrib><creatorcontrib>Guru Prasad, K.</creatorcontrib><creatorcontrib>Gangu Naidu, Ch</creatorcontrib><creatorcontrib>Maurya, Pawan K.</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nageswara Rao, R.</au><au>Guru Prasad, K.</au><au>Gangu Naidu, Ch</au><au>Maurya, Pawan K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>56</volume><issue>3</issue><spage>471</spage><epage>478</epage><pages>471-478</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>A simple and rapid reversed phase liquid chromatographic method for separation and determination of the related substances of telmisartan (TLM) was developed and validated. The chromatographic separation was achieved on Lichrospher RP-18 column (250×4.6mm, 5μm), using 20mM ammonium acetate containing 0.1% (v/v) triethylamine (pH adjusted to 3.0 with trifluoroacetic acid) and acetonitrile as mobile phase at 25°C. The detection was performed at 254nm. The method was validated and found to be robust, precise, specific and linear between 0.37 and 500μg/mL. The limits of detection and quantification of telmisartan were 0.11 and 0.37μg/mL, respectively. The method was successfully applied to quantify related substances and assay of TLM in bulk drugs and commercial tablets. The related substances relate to a novel synthetic route and different from those A-H impurities reported by European Pharmacopeia.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>21719227</pmid><doi>10.1016/j.jpba.2011.05.043</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2011-11, Vol.56 (3), p.471-478
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_882127626
source ScienceDirect Journals
subjects acetonitrile
Acetonitriles - analysis
Acetonitriles - chemistry
ammonium acetate
Analysis
Analytical, structural and metabolic biochemistry
Benzimidazoles - analysis
Benzimidazoles - chemistry
Benzoates - analysis
Benzoates - chemistry
Biological and medical sciences
Bulk drugs
Chemistry, Pharmaceutical - methods
Chromatography, Liquid - methods
detection limit
Drug Contamination
Ethylamines - analysis
Ethylamines - chemistry
Fundamental and applied biological sciences. Psychology
General pharmacology
Hypertension
Medical sciences
Pharmacology. Drug treatments
Quality Control
Related substances
Reproducibility of Results
reversed-phase liquid chromatography
RP-HPLC
Tablets - analysis
Tablets - chemistry
Telmisartan
triethylamine
title Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A34%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%20validated%20liquid%20chromatographic%20method%20for%20determination%20of%20related%20substances%20of%20telmisartan%20in%20bulk%20drugs%20and%20formulations&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Nageswara%20Rao,%20R.&rft.date=2011-11-01&rft.volume=56&rft.issue=3&rft.spage=471&rft.epage=478&rft.pages=471-478&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/j.jpba.2011.05.043&rft_dat=%3Cproquest_cross%3E882127626%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-e48e7aa669255776d9d62a082556276bd98f09738ab97063d07220ce6ca869143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=882127626&rft_id=info:pmid/21719227&rfr_iscdi=true